NBTY, Inc. 

(Public, NYSE:NTY)   Watch this stock   
Find more results for NTY
Nov 19, 2009
Citi Small/Mid Cap Conference
Nov 9, 2009
Q4 2009 Earnings Conference Call - Webcast
Nov 9, 2009
Q4 2009 Earnings Release
Sep 23, 2009
CanaccordAdams Healthy Living Conference
Sep 22, 2009
UBS Global Life Sciences Conference
Sep 17, 2009
CL King and Associates Best Ideas Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 9.38% 5.64%
Operating margin 15.92% 10.22%
EBITD margin - 12.89%
Return on average assets 13.23% 7.48%
Return on average equity 23.13% 13.71%
Employees 13,760 -

Address

2100 Smithtown Avenue
Ronkonkoma, NY 11779
United States - Map
+1-631-5679500 (Phone)
+1-631-5677148 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

NBTY, Inc. discussed on blogs

Ranking 700+ Mid-Cap Stocks by Profit Margin - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

NBTY, Inc. discussions

  View all discussions »

Description

NBTY, Inc. (NBTY) is a vertically integrated manufacturer, marketer and retailer of a line of nutritional supplements in the United States and throughout the world. The Company markets approximately 25,000 products under numerous brands, including Nature’s Bounty, Vitamin World, Pure Protein, Body Fortress, Puritan's Pride, Holland & Barrett, Rexall, Osteo Bi-Flex, Flex-A-Min, Knox, Sundown, MET-Rx, WORLDWIDE Sport Nutrition, American Health, DeTuinen, Le Naturiste, SISU, Solgar, Physiologics and Ester-C. The Company’s vertical integration includes the purchase of raw materials, formulation and manufacture of products, which it markets through the four channels of distribution: Wholesale/United States Nutrition, North American Retail, European Retail and Direct Response/E-Commerce. During the fiscal year ended September 30, 2008 (fiscal 2008), the Company manufactured approximately 90% of the nutritional supplements it sold. On September 16, 2008, it acquired Julian Graves.

Officers and directors

Scott Rudolph
Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation - Reuters
Harvey Kamil
President, Chief Financial Officer
Age: 64
Bio & Compensation - Reuters
Hans Lindgren
Senior Vice President - Operations, Corporate Secretary
Age: 48
Bio & Compensation - Reuters
James P. Flaherty
Senior Vice President - Marketing and Advertising
Age: 50
Bio & Compensation - Reuters
Glenn Schneider
Senior Vice President, Assistant to the Chief Executive Officer
Age: 39
Bio & Compensation - Reuters
Arthur Rudolph
Director
Age: 80
Bio & Compensation - Reuters
Aram G. Garabedian
Director
Age: 73
Bio & Compensation - Reuters
Glenn Cohen
Director
Age: 49
Bio & Compensation - Reuters
Michael L. Ashner
Director
Age: 56
Bio & Compensation - Reuters
Peter J. White
Director
Age: 54
Bio & Compensation - Reuters